Evaluation of dorzolamide/timolol fixed combination therapy for the patients who need more IOP reduction under PG analogues
Not Applicable
- Conditions
- primary open angle glaucoma, ocular hypertension
- Registration Number
- JPRN-UMIN000004596
- Lead Sponsor
- Department of Ophthalmology, Kyoto Prefectural University of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1) patients who received any surgical therapy within the past 3 months (incl. laser surgery) 2) difficult to measure IOP with GAT 3) difficult to check the fundus due to the corneal opacity or cataract 4) any patients who are expected to receive any surgical procedures during the study periods 5) contraindication of beta blockers or dorzolamide 6) any allergic history to the timilol or dorzolamide 7) women who are under pregnant or lactation period 8) any one who is considered to be inappropriate for this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method intraocular pressure, ocular and general side effects
- Secondary Outcome Measures
Name Time Method